In the November 15th 2023 issue of Spine in the article by Suri et al, “Repurposing Antihypertensive and Statin

Medications for Spinal Pain: A Mendelian Randomization Study”, the following text was incorrectly included in the abstract. These are the “Key Points”, a journal-specific type of content that is distinct from the abstract, and should have been included at the end of the article:

“This Mendelian randomization study examined whether antihypertensive medications (beta-blockers, calcium channel blockers, and angiotensin-converting enzyme inhibitors) and statins can be repurposed to prevent or treat spinal.

This was a two-sample MR study using publicly available summary statistics from large-scale genome-wide association studies ranging size from 173,082 to 1,028,947 adults.

While no statistically significant associations were found, a protective effect of beta-blockers on spinal pain was suggested (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.72 to 0.98; p=0.03), as was a detrimental effect of calcium channel blockers on spinal pain (OR 1.12, 95% CI 1.02 to 1.24; p=0.02).”

The online version of this article has been corrected.

1. Suri P, Elgaeva EE, Williams FMK, et al. Repurposing antihypertensive and statin medications for spinal pain: a Mendelian randomization study. Spine. 2023;48:1568–74.